Yubin Wu

Key Laboratory Of Industrial Ecology And Environmental Engineering
Dalian, 116024, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Comparative effectiveness of PDMS passive sampling versus Tenax-TA extraction for assessing bioavailable SVOCs in soils and their bioaccumulation in rice grains.

Comparative effectiveness of PDMS passive sampling versus Tenax-TA extraction for assessing bioavailable SVOCs in soils and their bioaccumulation in rice grains.

Journal: Journal of hazardous materials

Published: January 13, 2026

CypA inhibition attenuates diabetic hypoglycemia-induced cognitive impairment via the CD147/NF-κB/MMP-9 pathway.

CypA inhibition attenuates diabetic hypoglycemia-induced cognitive impairment via the CD147/NF-κB/MMP-9 pathway.

Journal: Biochemical pharmacology

Published: September 23, 2025

From PDMS-based exposure profiling to machine learning-predicted serum concentrations: SVOC exposure disparities across occupational and environmental scenarios.

From PDMS-based exposure profiling to machine learning-predicted serum concentrations: SVOC exposure disparities across occupational and environmental scenarios.

Journal: Environmental science. Processes & impacts

Published: June 19, 2025

Exposure experiments and machine learning revealed that personal care products can significantly increase transdermal exposure of SVOCs from the environment.

Exposure experiments and machine learning revealed that personal care products can significantly increase transdermal exposure of SVOCs from the environment.

Journal: Journal of hazardous materials

Published: December 13, 2024

Lactate supplementation after hypoglycemia alleviates cognitive dysfunction induced by recurrent non-severe hypoglycemia in diabetic mice.

Lactate supplementation after hypoglycemia alleviates cognitive dysfunction induced by recurrent non-severe hypoglycemia in diabetic mice.

Journal: Experimental neurology

Published: July 20, 2024

Activation of mitophagy improves cognitive dysfunction in diabetic mice with recurrent non-severe hypoglycemia.

Activation of mitophagy improves cognitive dysfunction in diabetic mice with recurrent non-severe hypoglycemia.

Journal: Molecular and cellular endocrinology

Published: August 28, 2023

Mitophagy disorder mediates cardiac deterioration induced by severe hypoglycemia in diabetic mice.

Mitophagy disorder mediates cardiac deterioration induced by severe hypoglycemia in diabetic mice.

Journal: Molecular and cellular endocrinology

Published: April 15, 2023

Low FT3/FT4 Ratio Is Linked to Poor Prognosis of Acute Myocardial Infarction in Euthyroid Patients with Type 2 Diabetes Mellitus.

Low FT3/FT4 Ratio Is Linked to Poor Prognosis of Acute Myocardial Infarction in Euthyroid Patients with Type 2 Diabetes Mellitus.

Journal: Journal of clinical medicine

Published: September 28, 2022

Mito-TEMPO, a Mitochondria-Targeted Antioxidant, Improves Cognitive Dysfunction due to Hypoglycemia: an Association with Reduced Pericyte Loss and Blood-Brain Barrier Leakage.

Mito-TEMPO, a Mitochondria-Targeted Antioxidant, Improves Cognitive Dysfunction due to Hypoglycemia: an Association with Reduced Pericyte Loss and Blood-Brain Barrier Leakage.

Journal: Molecular neurobiology

Published: June 28, 2022

SIRT3 alleviates mitochondrial dysfunction induced by recurrent low glucose and improves the supportive function of astrocytes to neurons.

SIRT3 alleviates mitochondrial dysfunction induced by recurrent low glucose and improves the supportive function of astrocytes to neurons.

Journal: Free radical biology & medicine

Published: May 08, 2022

Severe Hypoglycemia Contributing to Cognitive Dysfunction in Diabetic Mice Is Associated With Pericyte and Blood-Brain Barrier Dysfunction.

Severe Hypoglycemia Contributing to Cognitive Dysfunction in Diabetic Mice Is Associated With Pericyte and Blood-Brain Barrier Dysfunction.

Journal: Frontiers in aging neuroscience

Published: September 13, 2021

Glucagon-like peptide-1 analogs mitigate neuroinflammation in Alzheimer's disease by suppressing NLRP2 activation in astrocytes.

Glucagon-like peptide-1 analogs mitigate neuroinflammation in Alzheimer's disease by suppressing NLRP2 activation in astrocytes.

Journal: Molecular and cellular endocrinology

Published: May 29, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026